Nakamoto, Inc. (NAKA)

7.19 -0.90 (-11.12%) USD  |  NASDAQ  |  Oct 16, 16:00
7.27 +0.08 (+1.11%) After-Hours: 18:24
More

Nakamoto SG&A Expense (TTM) : 24.53M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 24.53M
March 31, 2026 20.95M
December 31, 2025 11.76M
September 30, 2025 7.291M
June 30, 2025 2.834M
March 31, 2025 2.174M
December 31, 2024 1.907M
September 30, 2024 1.508M
June 30, 2024 1.340M
Date Value
March 31, 2024 1.298M
December 31, 2023 1.356M
September 30, 2023 1.197M
June 30, 2023 1.961M
March 31, 2023 1.904M
December 31, 2022 1.742M
September 30, 2022 1.706M
June 30, 2022 0.5843M
March 31, 2022 0.2216M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Astrana Health, Inc. 238.52M
Agilon Health, Inc. 259.04M
Starling Oncology, Inc. 111.45M
American Oncology Network, Inc. --
Regional Health Properties, Inc. 0.00